The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Oxaliplatin, 5FU and nab-paclitaxel as neoadjuvant regimen in patients with resectable oesogastric adenocarcinoma: A GERCOR phase 2 study (FOXAGAST).
 
Sarah Sophie Watson
No Relationships to Disclose
 
Christelle De La Fouchardiere
Consulting or Advisory Role - Amgen; Bayer; Bristol-Myers Squibb; Lilly; Roche; Shire
Research Funding - Roche
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Celgene; Roche
 
Stefano Chong Hun Kim
No Relationships to Disclose
 
Romain Cohen
Consulting or Advisory Role - Amgen; Sanofi
Travel, Accommodations, Expenses - Sanofi
 
Jean-Baptiste Bachet
Employment - Merck (I)
Honoraria - Amgen; Bayer; Celgene; Merck; Roche; Sanofi; SERVIER; Shire
Consulting or Advisory Role - Amgen; Bayer; Merck; SERVIER
Travel, Accommodations, Expenses - Amgen; Merck; Roche
 
Christophe Tournigand
Honoraria - Sanofi
Travel, Accommodations, Expenses - Sanofi
 
Jean-Marc Ferraz
No Relationships to Disclose
 
Marine Lefevre
No Relationships to Disclose
 
Delphine Colin
No Relationships to Disclose
 
Magali Svrcek
Consulting or Advisory Role - Bristol-Myers Squibb
 
Aurelia Meurisse
No Relationships to Disclose
 
Christophe Louvet
Consulting or Advisory Role - Celgene; MSD Oncology; Roche
Travel, Accommodations, Expenses - MSD Oncology; Roche